Hanimune Therapeutics

Based in the United States, Hanimune Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.

Hanimune Therapeutics develops consumer food products designed to prevent and manage food allergies by delivering controlled doses of common allergens to build tolerance, including products like 'Lil Mixins' for early infant allergen introduction and 'Top9Proteins' formulations with consistent allergen quantities.